Total Payments
$427.10
2024 Payments
$68.68
Companies
8
Transactions
20
Medicare Patients
1,513
Medicare Billing
$198,478
Payment Breakdown by Category
Food & Beverage$337.11 (78.9%)
Education$89.99 (21.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $337.11 | 19 | 78.9% |
| Education | $89.99 | 1 | 21.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $107.82 | 2 | $0 (2017) |
| Antares Pharma, Inc. | $76.24 | 5 | $0 (2024) |
| Teleflex LLC | $55.74 | 2 | $0 (2021) |
| Janssen Biotech, Inc. | $53.22 | 2 | $0 (2017) |
| Endo Pharmaceuticals Inc. | $43.67 | 3 | $0 (2024) |
| TOLMAR Pharmaceuticals, Inc. | $37.98 | 3 | $0 (2018) |
| PROCEPT BioRobotics Corporation | $37.34 | 2 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $15.09 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $68.68 | 4 | PROCEPT BioRobotics Corporation ($37.34) |
| 2023 | $60.56 | 4 | Endo Pharmaceuticals Inc. ($29.44) |
| 2022 | $28.10 | 2 | Antares Pharma, Inc. ($28.10) |
| 2021 | $70.74 | 3 | Teleflex LLC ($55.74) |
| 2018 | $12.23 | 1 | TOLMAR Pharmaceuticals, Inc. ($12.23) |
| 2017 | $186.79 | 6 | Astellas Pharma US Inc ($107.82) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/22/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $18.78 | General |
| Category: UROLOGY | ||||||
| 08/12/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 06/26/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $18.56 | General |
| Category: UROLOGY | ||||||
| 02/12/2024 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: UROLOGY | ||||||
| 09/20/2023 | Supernus Pharmaceuticals, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 09/11/2023 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: UROLOGY | ||||||
| 04/12/2023 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: UROLOGY | ||||||
| 01/11/2023 | Antares Pharma, Inc. | NOCDURNA (Drug), XYOSTED, TLANDO | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
| 06/08/2022 | Antares Pharma, Inc. | NOCDURNA (Drug), XYOSTED, TLANDO | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
| 02/16/2022 | Antares Pharma, Inc. | NOCDURNA (Drug), XYOSTED | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
| 11/10/2021 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Testosterone Replacement Therapy | ||||||
| 10/07/2021 | Teleflex LLC | UroLift System (Device) | Food and Beverage | In-kind items and services | $37.26 | General |
| Category: Interventional Urology | ||||||
| 10/07/2021 | Teleflex LLC | UroLift System (Device) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: Interventional Urology | ||||||
| 11/21/2018 | TOLMAR Pharmaceuticals, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $12.23 | General |
| Category: Prostate Cancer | ||||||
| 10/18/2017 | Astellas Pharma US Inc | Myrbetriq (Drug), Xtandi | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: Urology | ||||||
| 08/14/2017 | TOLMAR Pharmaceuticals, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Prostate Cancer | ||||||
| 06/07/2017 | TOLMAR Pharmaceuticals, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: Prostate Cancer | ||||||
| 05/22/2017 | Janssen Biotech, Inc. | PREZCOBIX (Drug) | Food and Beverage | In-kind items and services | $39.48 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 05/01/2017 | Astellas Pharma US Inc | — | Education | In-kind items and services | $89.99 | General |
| 03/08/2017 | Janssen Biotech, Inc. | ZYTIGA (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 365 | 775 | $202,865 | $47,011 |
| 2022 | 5 | 343 | 872 | $222,562 | $54,878 |
| 2021 | 6 | 391 | 1,010 | $192,744 | $56,355 |
| 2020 | 7 | 414 | 1,076 | $166,307 | $40,235 |
Total Patients
1,513
Total Services
3,733
Medicare Billing
$198,478
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 155 | 525 | $156,975 | $36,491 | 23.2% |
| 76857 | Limited ultrasound scan of pelvis | Office | 2023 | 80 | 101 | $16,362 | $3,803 | 23.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 38 | 38 | $14,022 | $3,149 | 22.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 13 | 13 | $10,998 | $2,553 | 23.2% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 79 | 98 | $4,508 | $1,015 | 22.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 138 | 587 | $166,963 | $41,611 | 24.9% |
| 76857 | Limited ultrasound scan of pelvis | Office | 2022 | 71 | 111 | $17,955 | $4,406 | 24.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 19 | 20 | $16,498 | $4,337 | 26.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 44 | 44 | $16,032 | $3,321 | 20.7% |
| 51741 | Electronic assessment of bladder emptying | Office | 2022 | 71 | 110 | $5,114 | $1,203 | 23.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 136 | 608 | $147,136 | $43,839 | 29.8% |
| 76857 | Ultrasound of pelvis, limited, not pregnancy related | Office | 2021 | 62 | 98 | $15,778 | $4,169 | 26.4% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2021 | 15 | 16 | $10,160 | $3,436 | 33.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 40 | 40 | $14,080 | $3,410 | 24.2% |
| 51741 | Electronic assessment of bladder emptying | Office | 2021 | 62 | 94 | $4,512 | $1,153 | 25.6% |
| 81003 | Automated urinalysis test | Office | 2021 | 76 | 154 | $1,078 | $346.50 | 32.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 123 | 504 | $121,968 | $29,039 | 23.8% |
| 76857 | Ultrasound of pelvis | Office | 2020 | 56 | 82 | $13,202 | $3,218 | 24.4% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2020 | 12 | 15 | $9,525 | $2,642 | 27.7% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 25 | 25 | $8,800 | $2,060 | 23.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 12 | 12 | $6,384 | $1,541 | 24.1% |
| 51741 | Electronic assessment of bladder emptying | Office | 2020 | 57 | 82 | $3,936 | $950.00 | 24.1% |
| 81003 | Automated urinalysis test | Office | 2020 | 129 | 356 | $2,492 | $784.05 | 31.5% |
About Dr. Nathaniel Peardon, D.O
Dr. Nathaniel Peardon, D.O is a Urology healthcare provider based in Holmdel, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1417996604.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nathaniel Peardon, D.O has received a total of $427.10 in payments from pharmaceutical and medical device companies, with $68.68 received in 2024. These payments were reported across 20 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($337.11).
As a Medicare-enrolled provider, Peardon has provided services to 1,513 Medicare beneficiaries, totaling 3,733 services with total Medicare billing of $198,478. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Holmdel, NJ
- Active Since 06/05/2006
- Last Updated 07/08/2007
- Taxonomy Code 208800000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1417996604
Products in Payments
- UroLift System (Device) $55.74
- XYOSTED (Drug) $47.20
- NOCDURNA (Drug) $44.13
- XIAFLEX (Biological) $43.67
- PREZCOBIX (Drug) $39.48
- ELIGARD (Drug) $37.98
- AQUABEAM SYSTEM (Device) $37.34
- Myrbetriq (Drug) $17.83
- ZYTIGA (Drug) $13.74
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.